Morphic Therapeutic

Read more
Praveen Tipirneni's photo - President & CEO of Morphic Therapeutic

President & CEO

Praveen Tipirneni

CEO Approval Rating

86/100

Founded:

2015

Status:

PublicIndependent CompanyNASDAQMORF

MORPHIC THERAPEUTIC TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Galectin is perceived as one of Morphic Therapeutic's biggest rivals. Galectin was founded in 2000, and is headquartered in Norcross, Georgia. Galectin is in the Pharmaceuticals industry. Galectin generates $41.6M less revenue vs. Morphic Therapeutic.

Indalo Therapeutics is a top competitor of Morphic Therapeutic. Indalo Therapeutics is a Private company that was founded in 2014 in Cambridge, Massachusetts. Like Morphic Therapeutic, Indalo Therapeutics also operates in the Health Care Services space. Compared to Morphic Therapeutic, Indalo Therapeutics has 56 fewer employees.

Blade Therapeutics is Morphic Therapeutic's #3 rival. Blade Therapeutics is headquartered in South San Francisco, California, and was founded in 2015. Blade Therapeutics operates in the Biotechnology industry. Blade Therapeutics generates 5.87% the revenue of Morphic Therapeutic.

Morphic Therapeutic Quarterly and Annual Revenue

Trailing 12-Months Trend (TTM)

Annual Revenue

$42.6M

Morphic Therapeutic's revenue is the ranked 4th among it's top 10 competitors. The top 10 competitors average 69.6M. Over the last four quarters, Morphic Therapeutic's revenue has decreased by 57.6%. Specifically, in Q1 2021's revenue was $3.3M; in Q4 2020, it was $5.9M; in Q3 2020, it was $25.8M; in Q2 2020, Morphic Therapeutic's revenue was $7.7M.

Morphic Therapeutic Acquisitions

No recent acquisitions found related to Morphic Therapeutic

Morphic Therapeutic Funding History

ROUND

FUNDING DATE

AMOUNT

INVESTORS

IPO
Jun 2019
$90M
-
Series B
Sep 2018
$80M
Series A
Jun 2016
$51.5M

Morphic Therapeutic Investments

No recent investments found related to Morphic Therapeutic

Morphic Therapeutic News

Morphic Therapeutic Press Releases

Social Media

Morphic Therapeutic Headquarters

35 Gatehouse Drive A-2

Waltham, Massachusetts02451

781-996-0955

Driving Directions »

Trending Companies

Morphic Therapeutic Summary

ABOUT

Overview

Morphic Therapeutic develops and commercializes oral integrin drugs for the treatment of immunological, fibrotic and neoplastic diseases. Morphic Therapeutic was founded in 2015. Morphic Therapeutic's headquarters is located in Waltham, Massachusetts,...

CEO

Morphic Therapeutic's President & CEO, Praveen Tipirneni, currently has an approval rating of 86%. Morphic Therapeutic's primary competitors are Galectin, Indalo Therapeutics & Blade Therapeutics.

Frequently Asked Questions about Morphic Therapeutic

  1. When was Morphic Therapeutic founded?

    Morphic Therapeutic was founded in 2015
  2. Who is Morphic Therapeutic's CEO?

    Morphic Therapeutic's CEO is Praveen Tipirneni
  3. How much revenue does Morphic Therapeutic generate?

    Morphic Therapeutic generates $42.6M in revenue
  4. How much funding does Morphic Therapeutic have?

    Morphic Therapeutic has historically raised $221.5M in funding
  1. Where is Morphic Therapeutic's headquarters?

    Morphic Therapeutic's headquarters is in Waltham Massachusetts, USA
  2. How many employees does Morphic Therapeutic have?

    Morphic Therapeutic has 76 employees
  3. What sector does Morphic Therapeutic operate in?

    Morphic Therapeutic is in Health Care Services
  4. Who are Morphic Therapeutic's competitors?

    Morphic Therapeutic's top competitors are Galectin, Indalo Therapeutics, Blade Therapeutics